PRINT ISSN: 0258-851X
ONLINE ISSN: 1791-7549
In Vivo is an international journal designed to bring together original high quality works and reviews on experimental and clinical biomedical research within the frames of human physiology, pathology and disease management. IN VIVO was established in 1987 by J.G. Delinasios. In this site you may find information concerning the editorial board, editorial policy, submission of manuscripts, contents of previous volumes and a current list of accepted manuscripts.
All articles on SARS-Cov-2 and Covid-19 Disease can now be accessed here
The IN VIVO Special Issue on SARS-Cov-2 and Covid-19 Disease
is available OPEN ACCESS at Highwire
Original articles and reviews on SARS-Cov-2 and Covid-19 Disease are welcome to be submitted to
IN VIVO for peer-review and rapid publication upon acceptance
In Vivo, in Vitro and in Silico Characterization of Permanent and Biodegradable Implants
Guest Editors: Mike Barbeck, Ole Jung, Rumen Krastev, Meike Stiesch, Frank Walther
We aim to share new insights on material developments and properties alongside biomaterial interactions for tissue regeneration. We invite studies on new and existing biomaterials, including innovative processing techniques. Contributions in the form of reviews or original papers are highly encouraged for this Special Issue.
Suggested topics:
– Biomaterials
– Tissue regeneration
– Cell and tissue responses
– (Biomaterial-related) Inflammation
– Biomechanics
– Lattice Structures
– Damage evolution
– Surface modification
– Titanium/Ti6AL4V
– MagnesiumAdditive manufacturing
– Proteins at Biomaterial Surfaces
- Deadline for article(s) submission: December 31, 2024.
- The Instructions for Authors of In Vivo apply to this special issue, in the same way they apply to any IV issue.
- The special issue is scheduled for publication in May 2025.
- Manuscripts should be submitted for publication through our
online submission system: www.iiar-submissions.com.
Contents of Current Issue
Archive of All Online Issues (January 2004 – Present)
|
ANTICANCER RESEARCH USA, Inc.
111 Bay Avenue, Highlands, NJ 07732, USA.
e-mail: journals@iiar-anticancer.org
Information – Editorial & Production Office:
Managing Editor: G. J. Delinasios, International Institute of Anticancer Research,
1st km Kapandritiou- Kalamou Rd., P.O.Box 22, Kapandriti, Attiki 19014, Greece.
Tel & Fax : +30-22950-52945, +30-22950-53389
e-mail:journals@iiar-anticancer.org